Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis)-Reference-Cited by-同舟云学术

Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis)

Published:2014-06-13 Issue:1 Volume:232 Page:155-164
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Miyaoka Tsuyoshi,Furuya Motohide,Horiguchi Jun,Wake Rei,Hashioka Sadayuki,Tohyama Masaya,Mori Norio,Minabe Yoshio,Iyo Masaomi,Ueno Shyuichi,Ezoe Sachiko,Murotani Kenta,Hoshino Syuzo,Seno Haruo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-014-3645-8.pdf

Reference53 articles.

1. Aizawa R, Kanbayashi T, Saito Y, Ogawa Y, Sugiyama T, Kitajima T, Kaneko Y, Abe M, Shimizu T (2002) Effects of yoku-kan-san-ka-chimpi-hange on the sleep of normal healthy adult subjects. Psychiatry Clin Neurosci 56:303–304

2. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, text revision. APA: Washington, DC

3. Anderson G, Berk M, Dodd S, Bechter K, Altamura AC, Dell’osso B, Kanba S, Monji A, Fatemi SH, Buckley P, Debnath M, Das UN, Meyer U, Muller N, Kanchanatawan B, Maes M (2013) Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 42:1–4

4. Citrone L, Meng X, Hochfeld M (2011) Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis. Schizophr Res 131:75–81

5. Conley RR, Buchanan RV (1997) Evaluation of treatment-resistant schizophrenia. Schizophr Bull 23:663–674

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Analysis of Yi-Gai-San's Multifaceted Mechanisms for Tremor-dominant Parkinson's Disease via Network Pharmacology and Molecular Docking Validation;Current Medicinal Chemistry;2024-11

2. Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis “Nutra NMA SCZ”;Molecular Psychiatry;2024-07-18

3. Global perspectives on the traditional approaches used in the treatment of schizophrenia: A systematic review;Asian Journal of Psychiatry;2024-07

4. Efficacy of pharmacological agents for the management of treatment-resistant schizophrenia: a network meta-analysis;Expert Review of Clinical Pharmacology;2024-01-26

5. Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis;2024-01-12